← SynDRA
ODANACATIB
SynDRA canonical compound SYN0014302 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | CTSK |
| Mechanism of action | Cathepsin inhibitor |
All known targets
Mechanisms of action (all sources)
- Cathepsin inhibitor
- CTSK INHIBITOR
- Cathepsin K inhibitor
Cross-references
Synonyms
- L-001037536
- L-1037536
- MK-0822
- MK0822
- MK 0822
- MK-0822A
- Odanacatib (USAN)
- Odanacatib (MK 0822)
- Odanacatib (MK0822)
- CHEMBL481611
- N673F6W2VH
- (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethyl)amino)pentanamide
- (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- (S)-N-(1-CYANOCYCLOPROPYL)-4-FLUORO-4-METHYL-2-((S)-2,2,2-TRIFLUORO-1-(4'-(METHYLSULFONYL)BIPHENYL-4-YL)ETHYLAMINO)PENTANAMIDE
- Odanacatib [USAN]
- Odanacatib [USAN:INN]
- UNII-N673F6W2VH
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)pentanamide
- ODANACATIB [MI]
- ODANACATIB [INN]
- ODANACATIB [JAN]
- Odanacatib (JAN/USAN)
- ODANACATIB [MART.]
- ODANACATIB [WHO-DD]
- MLS006010197
- GTPL6478
- SCHEMBL1496266
- DTXSID40209075
- EX-A552
- BCPP000141
- cas:603139-19-1;Odanacatib
- BDBM50255753
- MFCD11042419
- NSC766811
- s1115
- ZINC42893657
- AKOS015900719
Look up ODANACATIB in the interactive SynDRA portal →